1.Artificial intelligence in medical imaging: From task-specific models to large-scale foundation models.
Yueyan BIAN ; Jin LI ; Chuyang YE ; Xiuqin JIA ; Qi YANG
Chinese Medical Journal 2025;138(6):651-663
Artificial intelligence (AI), particularly deep learning, has demonstrated remarkable performance in medical imaging across a variety of modalities, including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), and pathological imaging. However, most existing state-of-the-art AI techniques are task-specific and focus on a limited range of imaging modalities. Compared to these task-specific models, emerging foundation models represent a significant milestone in AI development. These models can learn generalized representations of medical images and apply them to downstream tasks through zero-shot or few-shot fine-tuning. Foundation models have the potential to address the comprehensive and multifactorial challenges encountered in clinical practice. This article reviews the clinical applications of both task-specific and foundation models, highlighting their differences, complementarities, and clinical relevance. We also examine their future research directions and potential challenges. Unlike the replacement relationship seen between deep learning and traditional machine learning, task-specific and foundation models are complementary, despite inherent differences. While foundation models primarily focus on segmentation and classification, task-specific models are integrated into nearly all medical image analyses. However, with further advancements, foundation models could be applied to other clinical scenarios. In conclusion, all indications suggest that task-specific and foundation models, especially the latter, have the potential to drive breakthroughs in medical imaging, from image processing to clinical workflows.
Humans
;
Artificial Intelligence
;
Deep Learning
;
Diagnostic Imaging/methods*
;
Magnetic Resonance Imaging
;
Tomography, X-Ray Computed
;
Positron-Emission Tomography
2.Simultaneous Determination of Loganic Acid and Isoscoparin in Sanwei Longdanhua Tablets by HPLC
Yueyan AI ; Xueyong ZHAO ; Lin FU ; Xiaolian BIAN ; Rui GU ; Jingbo ZHANG ; Nancuo ; Xiraonamu
China Pharmacy 2018;29(20):2810-2813
OBJECTIVE:To establish a method for the simultaneous determination of loganic acid and isoscoparin in Sanwei longdanhua tablets. METHODS:HPLC method was adopted. The determination was performed on Inertsil ODS-3 column with mobile phase consisted of methanol-0.2% phosphoric acid (gradient elution) at the flow rate of 1.0 mL/min. The detection wavelength was set at 240 nm,and column temperature was 30 ℃. The sample size was 10 μL. RESULTS:The linear range were 0.040 08-4.008 0 μg(r=0.999 9)for loganic acid and 0.021 96-2.196 0 μg(r=0.999 9)for isoscoparin. The quantitative limits were 0.160 32 and 0.087 8 ng/mL,and detection limits were 0.080 16 and 0.043 92 ng/mL. RSDs of precision,stability and reproducibility tests were all lower than 2%. The recoveries were 103.07%-104.26%(RSD=0.52%,n=6) and 95.57%-99.61%(RSD=1.55%,n=6). CONCLUSIONS:The method is simple,accurate and suitable for simultaneous determination of loganic acid and isoscoparin in Sanwei longdanhua tablets.

Result Analysis
Print
Save
E-mail